Developing new contraceptive methods for women, especially those who are obese.
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – CORE FUNCTION ACTIVITIES FOR SITES OF FEMALE CONTRACEPTIVE STUDIES - UTAH
This study is looking to create safer birth control options for women, especially those who are obese, to help prevent unintended pregnancies while keeping their health in mind.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-11126503 on NIH RePORTER |
What this research studies
This research focuses on creating new contraceptive methods that effectively prevent unintended pregnancies while also minimizing health risks, particularly for obese women who may face increased risks with current contraceptive options. The Contraceptive Clinical Trials Network (CCTN) will develop and implement clinical trial protocols aimed at evaluating the safety and efficacy of these new contraceptive agents. By involving women in clinical trials, the research seeks to address specific health concerns and improve contraceptive choices available to them.
Who could benefit from this research
Good fit: Ideal candidates for participation are women, especially those who are obese or have medical conditions that make current contraceptive methods unsuitable.
Not a fit: Patients who are not women or those who do not have concerns related to contraception may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective contraceptive options for women, particularly those at higher risk due to obesity.
How similar studies have performed: Previous research has shown promise in developing new contraceptive methods, but this specific approach targeting obese women is relatively novel.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Turok, David — University of Utah
- Study coordinator: Turok, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.